This inventor holds 3 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: The J. David Gladstone Institutes, Keio University. Active years: 2016-2023.
Company Filing History:
Years Active: 2016-2023
Title: Masaki Ieda: Innovator in Cellular Differentiation
Introduction
Masaki Ieda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cellular biology, particularly in the differentiation of somatic cells. With a total of three patents to his name, Ieda's work has the potential to impact regenerative medicine and therapeutic applications.
Latest Patents
Ieda's latest patents include a reagent for differentiating somatic cells into alveolar epithelial cells. This reagent comprises an NK2 homeobox family gene expression vector and a Fox family gene expression vector. The method for manufacturing alveolar epithelial cells involves forcing a somatic cell to express these genes and subsequently culturing the somatic cell after forced expression. Additionally, he has developed methods for generating cardiomyocytes from post-natal fibroblasts, providing cells and compositions for use in this process.
Career Highlights
Throughout his career, Masaki Ieda has worked with esteemed institutions such as the J. David Gladstone Institutes and Keio University. His research has focused on innovative methods for cellular differentiation, contributing to advancements in medical science.
Collaborations
Ieda has collaborated with notable colleagues, including Deepak Srivastava and Makoto Ishii. These partnerships have further enriched his research and development efforts in the field of cellular biology.
Conclusion
Masaki Ieda's innovative work in cellular differentiation showcases his commitment to advancing medical science. His patents and collaborations highlight his significant contributions to the field, paving the way for future developments in regenerative medicine.